Cyclosporin A inhibits monocyte tissue factor activation in cardiac transplant recipients

Circulation

Volumn 96, Issue 12, 1997, Pages 4232-4238

  Hölschermann, Hans ^a   Kohl, Oliver ^a   Maus, Ulrich ^a   Dürfeld, Frank ^a   Bierhaus, Angelika ^b   Nawroth, Peter P ^b   Lohmeyer, Jürgen ^a   Tillmanns, Harald ^a   Haberbosch, Werner ^a  

^a JUSTUS LIEBIG UNIVERSITY   (Germany)

^b UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Blood cells; Coagulation; Transplantation; Vasculature

Indexed keywords

CYCLOSPORIN A; GAMMA INTERFERON; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1BETA; THROMBOPLASTIN;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; ELECTROPHORETIC MOBILITY; FEMALE; GENE EXPRESSION; HEART TRANSPLANTATION; HUMAN; MACROPHAGE; MALE; MONOCYTE; MONONUCLEAR CELL; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 0344111145     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.96.12.4232     Document Type: Article

References (52)

1. Nemerson Y. Tissue factor and hemostasis. Blood. 1988;71:71-78.
2. Carson SD, Brozna JP. The role of tissue factor in the production of thrombin. Blood Coagul Fibrinolysis. 1993;4:281-292.
3. Carlsen E, Flatmark A, Prydz H. Cytokine-induced procoagulant activity in monocytes and endothelial cells: further enhancement by cyclosporine. Transplantation. 1988;46:575-580.
4. Drake TA, Ruf W, Morrissey JH, Edgington TS. Functional tissue factor activity is entirely cell surface expressed on lipopolysaccharide-stimulated human blood monocytes and a constitutively tissue factor-producing cell line. J Cell Biol. 1989;109:389-395.
5. Gregory SA, Kornbluth RS, Helin H, Remold HG, Edgington TS. Monocyte pro-coagulant inducing factor: a lymphokine involved in the T-cell instructed monocyte pro-coagulant response to antigen. J Immunol. 1986;141:3231-3239.
6. Osterud B, Flaestad T. Increased tissue thromboplastin activity in monocytes of patients with meningococcal infection: related to an unfavorable prognosis. Thromb Haemost. 1983;49:5-7.
7. Taylor FBJ, Chang A, Ruf W, Morrissey JH, Hinshaw L, Catlett R, Blick K, Edgington TS. Lethal E. coli septic shock is prevented by blocking tissue factor with monoclonal antibody. Circ Shock. 1991;33:127-134.
8. Rao LVM. Tissue factor as a tumor procoagulant. Cancer Metastasis Rev. 1992;11:249-266.
9. Jude B, Agraou B, McFadden EP, Susen S, Bauten C, Lepelley P, Vanhaesbroucke C, Devos P, Cosson A, Asseman P. Evidence for time-dependent activation of monocytcs in the systemic circulation in unstable angina but not in acute myocardial infarction or in stable angina. Circulation. 1994;90:1662-1668.
10. Marmur JD, Thiruvikraman SV, Fyfe BS, Guha A, Sharma SK, Ambrose JA, Fallon JT, Nemerson Y, Taubman MB. Identification of active tissue factor in human coronary atheroma. Circulation. 1996;94:1226-1232.
11. Halloran P, Aprile M, Haddad G, Rohinette M. The significance of elevated procoagulant activity in the monocytes of renal transplant recipients. Transplant Proc. 1982;14:669-672.
12. Hattler BG, Rocklin RE, Ward PA, Rickles FR. Functional features of lymphocytes recovered from a human renal allograft. Cell Immunol. 1973;9:289-296.
13. Labarrere CA, Pitts D, Halbrook H, Faulk WP. Tissue plasminogen activator, plasminogen activator inhibitor-1, and fibrin as indexes of clinical course in cardiac allograft recipients: an immunocytochemical study. Circulation. 1994;89:1599-1608.
14. Faulk WP, Labarrere CA. Vascular immunopathology and atheroma development in human allografted organs. Arch Pathol Lab Med. 1992;116:1337-1344.
15. Schroeder JS, Gao SZ, Hunt SA, Stinson EB. Accelerated graft coronary artery disease: diagnosis and prevention. J Heart Lung Transplant. 1992;11:S258-S265.
16. Kahan BD. Cyclosporine. N Engl J Med. 1989;321:1725-1738.
17. Handa N, Hatanaka M, Baumgartner WA, Reitz B, Sandford G, Esa AH, Herskowitz A. Late cyclosporine treatment ameliorates established coronary graft disease in rat allografts. Transplantation. 1993;56:535-540.
18. Anderson HO, Madsen G, Nordestgaard BG, Kjeldsen K, Slender S. Cyclosporine suppresses experimental transplant atherosclerosis. Transplant Proc. 1994;26:1738.
19. Hess ML, Hastillo A, Thompson JA, Sansonetti DJ, Szentpetery S, Barnhart G, Lower RR. Lipid mediators in organ transplantation: does cyclosporine accelerate coronary atherosclerosis? Transplant Proc. 1987;19:71-73.
20. Vassalli G, Kaski JC, Tousoulis D, Kiowski W, Turina M, Follath F, Gallino A. Low-dose cyclosporine treatment fails to prevent coronary luminal narrowing after heart transplantation. J Heart Lung Transplant. 1996;15:612-619.
21. Wong RL, Winslow CM, Cooper KD. The mechanism of action of cyclosporin A in the treatment of psoriasis. Immunol Today. 1993;14:69-74.
22. Ferns G, Reidy M, Ross R. Vascular effects of cyclosporine A in vivo and in vitro. Am J Pathol. 1990;137:403-413.
23. Jonasson L, Holm J, Hansson GK. Cyclosporin A inhibits smooth muscle proliferation in the vascular response to injury. Proc Natl Acad Sci U S A. 1988;85:2303-2306.
24. Hölschermann H, Dürfeld F, Maus U, Bierhaus A, Heidinger K, Lohmeyer J, Nawroth PP, Tillmanns H, Haberbosch W. Cyclosporine A inhibits tissue factor expression in monocytes/macrophages. Blood. 1996;88:3837-3845.
25. Boyum A. Isolation of mononuclear cells and granulocytes from human blood: isolation of mononuclear cells by one centrifugation and of granulocytes by combining centrifugation and sedimentation at 1g. Scand J Clin Lab Invest. 1963;21(suppl 97):77-89.
26. Chomczynski P, Sacchi N. Single step method of RNA-isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem. 1987;162:156-159.
27. Maus U, Rosseau S, Seeger W, Lohmeyer J. Separation of human alveolar macrophages by flow cytometry. Am J Physiol. 1997;272:L566-L571.
28. Scarpati EM, Wen D, Broze G, Miletich JP, Flandermayer RR, Siegel NR, Sadler E. Human tissue factor: cDNA-sequence and chromosome localization of the gene. Biochemistry. 1987;26:5234-5238.
29. Bierhaus A, Zhang Y, Deng Y, Mackman N, Quehenberger P, Haase M, Luther T, Müller M, Böhrer H, Greten J, Eike M, Bauerle P, Waldherr R, Kisiel W, Ziegler R, Stern DM, Nawroth PP. Mechanism of the TNFα mediated induction of endothelial tissue factor. J Biol Chem. 1995;270:26419-26432.
30. Camerer E, Kolsto A, Prydz H. Cell biology of tissue factor, the principal initiator of blood coagulation. Thromb Res. 1996;81:1-41.
31. Adams DH, Wyner LR, Steinbeck MJ, Karnovsky MJ. Inhibition of graft arteriosclerosis by modulation of the inflammatory response. Transplant Proc. 1993;25:2092-2094.
32. Kuwahara M, Jacobsson J, Kuwahara M, Kagan E, Ramwell PW, Foegh ML. Coronary artery ultrastructural changes in cardiac transplant atherosclerosis in the rabbit. Transplantation. 1991;52:759-765.
33. Lo SK, Cheung A, Zheng Q, Silverstein RL. Induction of tissue factor on monocytcs by adhesion to endothelial cells. J Immunol. 1995;154:4768-4777.
34. Libby P, Salomon RN, Payne DD, Schoen FJ, Pober JS. Functions of vascular wall cells related to the development of transplantation-associated arteriosclerosis. Transplant Proc. 1989;21:3677-3684.
35. Hosenpud JD, Shipley GD, Wagner CR. Cardiac allograft vasculopathy: current concepts, recent developments, and future directions. J Heart Lung Transplant. 1992;11:9-23.
36. Fan S-T, Edgington T-S. Coupling of the adhesive receptor CD11b/CD18 to functional enhancement of effector macrophage tissue factor response. J Clin Invest. 1991;87:50-57.
37. Fan S-T, Mackman N, Cui M-Z, Edgington TS. Integrin regulation of an inflammatory effector gene: direct induction of the tissue factor promotor by engagement of β1 or α4 integrin chains. J Immunol. 1995;154:3266-3274.
38. Gao SZ, Schroeder JS, Alderman EL, Hunt SA, Valantine HA, Wiederhold V, Stinson EB. Prevalence of accelerated coronary artery disease in heart transplant survivors: comparison of cyclosporine and azathioprine regimens. Circulation. 1989;80(suppl III):III-100-III-105.
39. Narrod J, Kormos R, Armitage J, Hardesty R, Ladowski J, Griffith B. Acute rejection and coronary artery disease in long-term survivors of heart transplantation. J Heart Transplant. 1989;8:418-420.
40. Treasure CB, Vita JA, Ganz P, Ryan TJJ, Schoen FJ, Vekshtein VI, Yeung AC, Mudge GH, Alexander RW, Selwyn AP. Loss of coronary microvascular response to acetylcholine in cardiac transplant recipients. Circulation. 1992;86:1156-1164.
41. Lim TT, Botas J, Ross H, Liang DH, Theodore J, Hunt S, Oesterle SN, Yeung AC. Are heart-lung transplant recipients protected from developing transplant coronary artery disease. Circulation. 1996;94:1573-1577.
42. Koskinen PK, Lemström KB, Hägry PK. How cyclosporine modifies histological and molecular events in the vascular wall during chronic rejection of rat cardiac allografts. Am J Pathol. 1995;146:972-980.
43. Mueller EA, Kovarik JM, van Bree JB, Lison AE, Kutz K. Pharmacokinetics and tolerability of a microemulsion formulation of cyclosporine in renal allograft recipients: a concentration-controlled comparison with the commercial formulation. Transplantation. 1994;57:1178-1182.
44. Schwager I, Jungi TW. Effect of human recombinant cytokines on the induction of macrophage procoagulant activity. Blood. 1994;83:152-160.
45. Oeth P, Parry GCN, Mackman N. Regulation of the tissue factor gene in human monocytic cells. Arterioscler Thromb Vasc Biol. 1997;17:365-374.
46. Alkalay I, Yaron A, Hatzubai A, Jung S, Avraham A, Gerlitz O, Pashut-Lavon I, Ben-Neriah Y. In vivo stimulation of IκB phosphorylation is not sufficient to activate NF-κB. Mol Cell Biol. 1995;15:1294-1301.
47. Edwards RL, Rickles FR. The role of human T cells and T cell products for monocyte tissue factor generation. J Immunol. 1980;125:606-609.
48. Levy GA, Schwartz BS, Edgington TS. The kinetics and metabolic requirements for direct lymphocyte induction of human procoagulant monokines by bacterial lipopolysaccharides. J Immunol. 1981;127:357-363.
49. Helin HJ, Edgington TS. Cyclosporin A regulates monocyte/macrophage effector functions by affecting instructor T cells: inhibition of monocyte procoagulant response to allogeneic stimulation. J Immunol. 1984;132:1074-1076.
50. Ferreira OC Jr, Barcinski MA. Autologous induction of the human T-cell-dependent monocyte procoagulant activity: a possible link between immunoregulatory phenomena and blood coagulation. Cell Immunol. 1986;101:259-265.
51. Di Padova FE. Pharmacology of cyclosporine (Sandimmune). Pharmacol Rev. 1989;41:373-405.
52. Emmel EA, Verweij CL, Durand DB, Higgins KM, Lacy E, Crabtree GR. Cyclosporin A specifically inhibits function of nuclear proteins involved in T cell activation. Science. 1989;246:1617-1619.